JPMorgan says it's time to buy these unloved safe stocks that pay dividends

JPMorgan says low-volatility stocks in the U.S. and Europe are at an attractive entry point after underperforming as bond yields rose 55 bps since the Middle East conflict began. The bank argues the trade can work across multiple macro scenarios, especially if yields stabilize or eventually trend lower, while also offering dividend income. Named examples include Coca-Cola (2.6% yield, about 9% upside), Rollins (1.37% yield, nearly 22% upside), and Procter & Gamble (3.01% yield, about 15% upside), all of which have solid analyst support despite recent weakness.

Analysis

This is less a “defensive rotation” story than a factor dislocation trade. Low-vol has been punished because the market is still paying for duration sensitivity: these balance-sheet cash flow names get sold when real yields back up, even if their own fundamentals are intact. That creates a cleaner entry point than in a typical late-cycle defensives bid, because the move has been driven more by macro beta compression than by any deterioration in earnings quality.

The second-order implication is that the upside is not just a rates call. If yields settle, the group can re-rate on carry; if yields spike, investors may still rotate into cash-generative staples/healthcare/utilities as equity volatility rises and broad multiples compress. That asymmetry matters because it means the trade can work in both “soft landing” and “stress” regimes, while cyclicals and long-duration growth lose on either path if the market stops rewarding optimistic rate expectations.

Within the basket, the best risk/reward is in names with visible dividend support plus recent post-earnings de-rating, not the highest-quality compounders that already trade as quasi-bonds. Consumer staples with pricing power and low input-cost exposure are better than pure bond proxies; pest control and essential services offer a stronger idiosyncratic earnings path than utilities. The main risk is a sharp upside surprise in yields that re-ignites factor de-grossing and keeps low-vol cheap for longer than fundamentals justify, but that scenario also tends to increase macro uncertainty and eventually supports the style on relative performance grounds.

Key Decisions for Investors

• Go long KO vs. broad market on a 3-6 month horizon; the setup is favorable because the stock has already de-rated versus its earnings durability. Target 8-10% upside with 4-5% downside if yields keep grinding higher but growth holds.
• Buy PG on weakness and hedge with a small short in XLP beta or a market index overlay; this isolates the idiosyncratic rerating from the macro factor noise. Use a 2-4 month horizon and trim if the stock reclaims its prior multiple range.
• Initiate a long ROL / short high-duration growth pair for a 6-month hold; ROL’s earnings visibility plus low leverage to rates should outperform if volatility stays elevated. Expect mid-single-digit absolute upside on the long leg with lower drawdown than the short leg.
• For tactical traders, sell put spreads on KO or PG 1-2 quarters out to monetize elevated implied volatility if the rates backdrop stabilizes. Structure strikes below recent lows to keep positive carry while defining risk.
• Avoid chasing utilities here; prefer staples/healthcare/essential services over pure yield proxies because the latter have weaker fundamental catalysts if rates back up again. Use any further yield spike as the better entry, not the current levels if the move is already extended.